[1]敬秀平,宋小平,刘 珊.加味白头翁汤灌肠治疗慢性溃疡性结肠炎临床研究[J].陕西中医,2021,(8):1060-1063.[doi:DOI:10.3969/j.issn.1000-7369.2020.08.018]
　JING Xiuping,SONG Xiaoping,LIU Shan.Study on the therapeutic effect and inflammatory mechanism of enema with modified Baitouweng decoction in the treatment of chronic ulcerative colitis[J].,2021,(8):1060-1063.[doi:DOI:10.3969/j.issn.1000-7369.2020.08.018]
点击复制

加味白头翁汤灌肠治疗慢性溃疡性结肠炎临床研究
分享到：

《陕西中医》[ISSN:1000-7369/CN:61-1281/TN]

卷:
期数:
2021年8期
页码:
1060-1063
栏目:
临床研究
出版日期:
2021-08-05

文章信息/Info

Title:
Study on the therapeutic effect and inflammatory mechanism of enema with modified Baitouweng decoction in the treatment of chronic ulcerative colitis
作者:
敬秀平; 宋小平; 刘 珊
(四川大学华西广安医院,四川 广安 638000)
Author(s):
JING Xiuping; SONG Xiaoping; LIU Shan
(West China Guang'an Hospital,Sichuan University,Guang'an 638000,China)
关键词:
慢性溃疡性结肠炎;  加味白头翁汤;  灌肠;  炎症机制;  肠黏膜征象积分;  肠道菌群
Keywords:
Chronic ulcerative colitis;  Modified Baitouweng decoction;  Enema;  Inflammatory mechanism;  Scores of intestinal mucosal signs;  Gut microbiota
分类号:
R 574.62
DOI:
DOI:10.3969/j.issn.1000-7369.2020.08.018
文献标志码:
A
摘要:
目的:研究加味白头翁汤灌肠治疗慢性溃疡性结肠炎(UC)的疗效及炎症机制。方法:选取102例慢性UC患者为对象,采用随机数字表法分为对照组50例和观察组52例,对照组给予美沙拉嗪灌肠液灌肠治疗,观察组给予加味白头翁汤灌肠治疗,比较两组临床疗效、中医证候积分、肠黏膜征象积分、炎性因子[白介素-10(IL-10)、白介素-13(IL-13)、白介素-8(IL-8)、肿瘤坏死因子-β(TNF-β)]水平、肠道菌群及不良反应发生率。结果:观察组治疗有效率高于对照组(90.38%与74.00%,P<0.05); 治疗后观察组中医证候积分、肠黏膜征象积分、IL-8、TNF-β、大肠埃希菌、肠球菌低于对照组,血清IL-10、IL-13、双歧杆菌、乳酸杆菌水平高于对照组(均P<0.05); 两组不良反应发生率比较无统计学差异(P>0.05)。结论:加味白头翁汤灌肠治疗慢性UC疗效显著,可缓解中医证候和肠黏膜征象,改善肠道菌群,其机制与下调IL-8、TNF-β和上调IL-10、IL-13水平有关。
Abstract:
Objective:To study the therapeutic effect and inflammatory mechanism of enema with modified Baitouweng decoction in the treatment of chronic ulcerative colitis(UC).Methods:102 patients with chronic UC were selected and divided into control group(n=50)and observation group(n=52)by random number method.The control group received enema with mesalamine,while the observation group received enema with modified Baitouweng decoction. The two groups were compared in terms of clinical effects,TCM syndrome scores,scores of intestinal mucosal signs,levels of inflammatory factors [interleukin-10(IL-10),interleukin-13(IL-13),interleukin-8(IL-8),tumor necrosis factor-β(TNF-β)],gut microbiota and the incidence of adverse reactions.Results:The effective rate of treatment in the observation group was 90.38%,higher than 74.00% in the control group(P<0.05).After treatment,the TCM syndrome scores,scores of intestinal mucosal sign,IL-8,TNF-β,Escherichia coli and Enterococcus in the observation group were lower than those in the control group.The levels of serum IL-10,IL-13,Bifidobacterium and Lactobacillus were higher than those in the control group(all P<0.05).There was no significant difference in the incidence of adverse reactions between the two groups(P>0.05).Conclusion:Enema with modified Baitouweng decoction is effective in the treatment of chronic UC.It can relieve TCM syndromes and intestinal mucosal signs,and improve gut microbiota.The mechanism is related to down-regulation of IL-8 and TNF-β,and up-regulation of IL-10 and IL-13 levels.

参考文献/References:

[1] 陈风慧,王晓华,范春梅,等.补充外源性维生素D对老年溃疡性结肠炎患者氧化-抗氧化失衡、肠道黏膜屏障和临床预后的影响[J].陕西医学杂志,2018,47(12):1424-1427.
[2] 杨淑娟,赵庆华,周永志,等.白头翁汤加减联合灌肠治疗溃疡性结肠炎湿热蕴结型临床研究[J].陕西中医,2018,39(3):331-333.
[3] 范永强,张瑞芳,陈红霞,等.白头翁汤加减治疗大肠湿热型溃疡性结肠炎疗效观察[J].中国中西医结合外科杂志,2019,25(4):474-477.
[4] 李 荣.芍药汤加味保留灌肠治疗慢性溃疡性结肠炎的疗效及预后的影响分析[J].四川中医,2019,37(9):99-102.
[5] 胡品津.炎症性肠病诊断与治疗的共识意见解读[J].胃肠病学,2012,17(12):709.
[6] 李国锐.中医病证诊断疗效标准[M].南京:南京大学出版社,1995:112.
[7] 国家食品药品监督管理总局.中药新药临床研究指导原则[M].北京:中国医药科技出版社,2002:125-126.
[8] 张 飞,韩国鑫,沈 洪,等.重症急性胰腺炎早期液体复苏与腹腔间隙综合征[J].中国急救复苏与灾害医学杂志,2017,12(3):212-214.
[9] Wang Q,Zhu HT,Wu GR,et al.Analysis on the therapeutic effects of integrated traditional Chinese and western medicine on ulcerative colitis and its effects on coagulation function and inflammatory factors[J].Journal of Hainan Medical University,2019,25(1):5-9.
[10] Liu SM,Tang YP,Wu WJ,et al.Effect of herbal decoction on NF-κB p65 and immune function in the ulcerative colitis mice with dampness heat syndrome[J].Chinese Journal of Integrative Medicine Surgery,2017,23(5):518-522.
[11] 崔 茜,田振国,隋 楠,等.葛根芩连汤内服联合白头翁汤加减保留灌肠治疗大肠湿热证溃疡性结肠炎患者疗效观察[J].辽宁中医药大学学报,2019,21(2):202-205.
[12] 崔国宁,刘喜平,董俊刚,等.白头翁汤治疗溃疡性结肠炎研究进展[J].山东中医药大学学报,2018,42(4):370-373.
[13] 葛曼青,巫玉兰,陈 轩,等.加味白头翁汤灌肠液治疗活动期湿热型溃疡性结肠炎大鼠疗效观察[J].检验医学与临床,2019,16(7):76-80.
[14] 朱方明.白头翁汤治疗溃疡性结肠炎临床研究[J].陕西中医,2017,38(1):31-33.
[15] 杨 云,赵红波,葛志明,等.加味白头翁汤灌肠治疗大肠湿热型溃疡性结肠炎疗效观察及对炎症因子水平影响[J].广州中医药大学学报,2018,35(2):242-247.
[16] 孙晓艳,王 锐,吉 强,等.白头翁汤加味联合保留灌肠治疗溃疡性结肠炎的临床疗效观察[J].世界中西医结合杂志,2018,13(3):366-369.
[17] 马乾章,李 云,丁原全,等.白头翁汤加味联合美沙拉嗪缓释片治疗热毒炽盛型溃疡性结肠炎的临床疗效观察[J].海南医学院学报,2019,25(12):918-922.
[18] 叶益平.白头翁汤治疗溃疡性结肠炎临床疗效及对血清炎症因子水平的影响[J].中华中医药学刊,2017,35(6):1627-1629.
[19] 谭玉娥,袁东红.双歧杆菌乳杆菌三联活菌片联合奥沙拉秦钠胶囊治疗溃疡性结肠炎疗效及对IL-1β和IL-10表达的影响[J].现代中西医结合杂志,2017,40(26):56-58.
[20] 唐 剑,杨怡玲.白头翁汤加味对湿热蕴结型溃疡性结肠炎患者血清TNF-α和IL-8的影响及疗效观察[J].北京中医药,2017,36(7):70-72.

备注/Memo

备注/Memo:
基金项目:四川省中医药管理局资助项目(2020LC0120)
更新日期/Last Update: 2021-08-09